Clinical Trials
4 trialsNCT02954523 2024-07-05
Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Georgetown University
Phase 1/2 Terminated
NCT00787267 2016-06-30
TOP0801
Duke University
Phase 2 Terminated
NCT01491633 2014-07-15
Dasatinib in Advanced Squamous Cell Lung Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT00858403 2014-01-15
Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated